Additionally, ACSL4 and KLF4 are key molecules in the ferroptosis signaling pathway; they can inhibit ferroptosis in breast cancer cells while maintaining their malignant biological characteristics (116, 136, 137). The gene discussed is ACSL4; the disease is breast carcinoma.